CDRE: Post Collapse Recovery detected on 30 Jul 2026

Cadre Holdings exhibits a post-collapse recovery pattern following elevated volatility earlier in the year. The stock trades at $30.54, positioned between key support at $26.87 and resistance at $34.23. Pattern quality metrics show moderate strength with structure score of 14.4, breakout score of 10.95, and volume score of 10.7 (combined into overall 74.05). Volume ratio of 1.42x average signals above-average participation. RSI sits at neutral 52.67 with positive MACD histogram (0.3084), indicating building upside momentum. Win probability registered at 69.6% suggests above-average breakout success probability for this setup.

First quarter 2026 results paired a record $355 million backlog with commentary on using mergers and acquisitions to expand its mission critical safety portfolio. Since January 2024, Cadre has deployed over $400 million in targeted M&A, including acquisition of Alien Gear Holsters. Q2 2026 earnings release scheduled for August 5, 2026, after market close, creating near-term catalyst risk. The 90-day share price return is down 32.86% and year-to-date return is down 29.18%, explaining the recovery setup. Health care sector regime shows bullish positioning (regime score 0.92), supporting upside potential. Beta of 1.91 reflects elevated volatility relative to broader market.

A successful breakout would see the stock clear the $34.23 resistance level with sustained volume above 440k shares. The measured move target from this recovery setup is $32.08 on the conservative basis, though breakout acceleration could push toward initial resistance. Invalidation occurs below key support of $26.87—breach below this level would signal pattern failure and likely mark resumption of downtrend. With 69.6% win probability, historical performance suggests this setup carries above-average odds of upside follow-through. Volume confirmation (ideally 1.5x+ average) on breakout above resistance is critical for pattern validation.

Earnings announcement scheduled August 5-6, 2026 creates binary catalyst risk just 6 days out—guidance or execution miss could trigger breakdown. Stock has underperformed significantly YTD (down 29.18%) and trades 40% below analyst price target, though this valuation reset may reflect cautious sentiment awaiting earnings. High beta of 1.91 amplifies downside risk in market corrections. Stock trades at 34.4x P/E ratio, above aerospace/defense average—if sentiment shifts or forecasts soften, valuation premium could reverse quickly. Near-term consolidation ahead of earnings (5 days) may limit upside until post-earnings clarity emerges.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.